SEOUL, May 12 (Yonhap) -- The World Health Organization (WHO) on Thursday launched the official steering committee for its new global biomanufacturing training hub in South Korea and confirmed its education plan for 2022, the health ministry here said.
In February, the U.N. health agency announced the decision to establish the global training hub in South Korea aimed at supporting low- and middle-income countries wishing to strengthen their biomanufacturing technology and production capabilities.
The steering committee, co-chaired by Lee Kang-ho, head of the South Korean health ministry's global vaccine hub operations, and WHO Chief Scientist Soumya Swaminathan, held its inaugural meeting via video links Thursday following four preparatory meetings.
In the meeting, the committee confirmed the plan for the hub's 2022 education program. The hub plans to offer biomanufacturing training to 370 industry personnel from developing countries and 140 domestic counterparts within the year.
The program will be centered on theoretical courses and on-site visits to manufacturing facilities until a dedicated global bio campus for participating trainees is established, according to officials.
In August of last year, the South Korean government announced its goal to become the world's fifth-largest vaccine-producing nation by 2025 by investing 2.2 trillion won (US$1.87 billion) in related industries.
(News Focus) BOK expected to seek further rate hikes but place more weight on growth: experts
Yoon to seek small gov't stance to spur economic growth
Having passed major regulatory hurdle for Intel deal, SK hynix eyes economies of scale, sharper competitive edge
Pandemic, election to put pressure on 2022 economic policy implementation
Midsized shipbuilders' orders bounce back after finalizing their sale deals